ecancer logo

ecancer disseminates the latest cancer news and research through multimedia channels. We believe the latest oncology information should be available free of charge to cancer communities around the world.

 
  • Update on Aspirin and Cancer Prevention Update on Aspirin and Cancer Prevention Professor Jack Cuzick reviews the latest research on the use of aspirin for cancer prevention, as reported at the Royal Society of Medicine in London.
  • EURECCA: A Consensus for Rectal Cancer Treatment? EURECCA: A Consensus for Rectal Cancer Treatment? Dr. Colette van den Broek discusses the multinational EURECCA study, which pooled data from 6597 patients with rectal cancer to develop European treatment guidelines.
  • Treatment Options in Castration-Resistant Prostate Cancer Treatment Options in Castration-Resistant Prostate Cancer An expert panel at the 2012 Prostate Cancer Debate in London discusses the evolving treatment options for patients with CRPC and the need for a multidisciplinary approach to optimize survival.
  • Recent Advances in Multiple Myeloma Therapy Recent Advances in Multiple Myeloma Therapy Professors Antonio Palumbo, Meletios Dimopoulos, Jesus San Miguel, Thierry Facon, and Philippe Moreau discuss the important developments in the treatment of multiple myeloma presented at ASH 2011.
  • Partial Breast IRT: New Standard for Early Breast Cancer? Partial Breast IRT: New Standard for Early Breast Cancer? Dr. Roberto Orecchia reports on the ELIOT study, which suggests that partial breast intraoperative radiation therapy may prove a new standard of care for a large segment of breast cancer patients.
  • Multiple Reasons to Attend a Multidisciplinary Congress Multiple Reasons to Attend a Multidisciplinary Congress ECCO and ESMO presidents highlight what to expect from the 2011 European Multidisciplinary Cancer Congress.
  • Stereotactic Radiotherapy Blasts Away at Early Lung Cancer Stereotactic Radiotherapy Blasts Away at Early Lung Cancer Stereotactic radiotherapy has a high impact on overall survival in patients with early lung cancer, but it requires quality-assurance procedures, says Dr. Rafal Dziadziuszko at EMCTO 2011.
  • FDG-PET Increases Treatment Efficacy in Lung Cancer FDG-PET Increases Treatment Efficacy in Lung Cancer Prof Dirk de Ruysscher reports that FDG-PET scans distinguish which parts of the tumor require high-dose radiotherapy, allowing for greater efficacy without increasing toxicity in NSCLC therapy.
  • CLL in the Elderly: Is the Game Plan Changing? CLL in the Elderly: Is the Game Plan Changing? Prof. Peter Hillmen, an expert in blood cancers, speaks about treatments available for elderly patients with CLL, focusing on options that offer deeper remission vs those that are better tolerated.
  • The Shock of Cancer: Helping Patients to Cope The Shock of Cancer: Helping Patients to Cope   Dr. Luzia Travado, an expert in psycho-oncology, discusses how treatment plans can be developed to help patients cope with issues arising from the distress they experience from having cancer.
  • Chemoradiotherapy Reduces Recurrence of Bladder Cancer Chemoradiotherapy Reduces Recurrence of Bladder Cancer   Prof. Nick James reports on his study which showed that combining fluorouracil and mitomycin C as radiosensitizers reduces locoregional recurrence of bladder cancer by 33%.
  • CyberKnife: The Cutting Edge in Lung Cancer CyberKnife: The Cutting Edge in Lung Cancer   Prof. Pierre-Yves Bondiau describes this radiosurgery tool, which allows radiation to be targeted very accurately and which tracks tumors as they move with the breathing motions of the lung.
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.